chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Breakthrough case after 4 vaccines: Pfizer 3/9/2021 batch/lot# EN6199; Pfizer 3/30/2021 batch/lot# ER8733; Moderna 11/12/2021 batch/lot# 051F21A; Moderna 4/5/2022 batch/lot# 066K21A.
Developed headache, dizziness, nausea, vomiting and soreness in right arm. Took Tylenol and slept until 9 PM. Awoke with headache and sore arm. Vomited x2 during night and once at school this morning (10/21). Can take liquids OK, not solids.
nausea; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced NAUSEA (nausea). At the time of the report, NAUSEA (nausea) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment medications were provided.  The patient Vaccination card  was unavailable
Patient given 2 vaccines on 10-14-113, started that night with left arm redness, fever 102 left arm red raised area. Started erythromycin and cetirizine for treatment of cellulitis.
c/o pain, swelling & limitation of ROM of lt shoulder on the day following inj; sx worsened given Ibuprofen, Rehab & (?); treating calcific tendinitis lt shoulder;
Pfizer 2/26/21 and 10/14/21. Positive on 1/17/22
Her arm is hurting; The pain moved from the arm to arm pit; This is a spontaneous report from a contactable consumer (patient) reporting on herself. A female patient of an unspecified age received BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced her arm was hurting on an unspecified date and the pain moved from the arm to arm pit on an unspecified. The outcome of both the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Red, raised, painful rash at site of injection. Roughly 5-8 inches in diameter.
Approximately 30 minutes after vaccine given to patient, patient c/o dizziness and flushing. Patient's arm warm to touch with significant swelling.  Patients vitals immediately taken and within normal limits. Patient advised to wait 15 more minutes. Within 10 minutes, patient was no longer experiencing dizziness and states that he "feels much better". He also stated that he may have been "just having anxiety" Advised by PA to take antihistamine. Patient voiced understanding.
1 or 2 days of feeling crummy after 3rd dose; blurry mind stuff; can't think clearly at times; a lot of fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (1 or 2 days of feeling crummy after 3rd dose), DAYDREAMING (blurry mind stuff), THINKING ABNORMAL (can't think clearly at times) and FATIGUE (a lot of fatigue) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011F21A) for COVID-19 vaccination.     Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA), ALPRAZOLAM, ASCORBIC ACID, TOCOPHERYL ACETATE, XANTOFYL, ZEAXANTHIN, ZINC (AREDS), CLONAZEPAM (KLONOPIN), PITAVASTATIN CALCIUM (LIVALO) and COLECALCIFEROL (VITAMIN D3) for an unknown indication.    On 24-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Sep-2021, the patient experienced FEELING ABNORMAL (1 or 2 days of feeling crummy after 3rd dose), DAYDREAMING (blurry mind stuff), THINKING ABNORMAL (can't think clearly at times) and FATIGUE (a lot of fatigue). At the time of the report, FEELING ABNORMAL (1 or 2 days of feeling crummy after 3rd dose), DAYDREAMING (blurry mind stuff), THINKING ABNORMAL (can't think clearly at times) and FATIGUE (a lot of fatigue) outcome was unknown.            No treatment information was provided by the reporter. Other concomitant medications: acidophilus ,Airborne gummies   ,Aller-Flo nasal spray   ,doxapin , Move Free Daily, multivitamin  , Premarin cream, zolpidem 5mg   ,Prolia injection   This case was linked to MOD-2021-356901, MOD-2021-356856 (Patient Link).
Took only 3 out of 4 Vivotif capsules; A spontaneous report was received from a nurse on 08SEP2022. Additional information was received on 09SEP2022. It described a female patient (unknown age) who "took only 3 out of 4 Vivotif capsules" (PT: Incomplete course of vaccination). The patient took the Vivotif capsule (typhoid vaccine live oral Ty21A) (lot number: unknown) for immunisation. It was reported that the patient has only taken 3 of her 4 Vivotif capsules and has left her fourth dose of Vivotif in the refrigerator of the place that she had been visiting and for which she would not be driving back. Additionally, it was reported that her last dose of Vivotif was due on 05SEP2022. The outcome of the reported event was not applicable.  Action taken with Vivotif with respect to the reported event was not applicable.  No additional information was reported.  Company comment: It was reported that a consumer took only 3 out of 4 Vivotif capsules (incomplete course of vaccination). Considering the case information, the causality of incomplete course of vaccination is assessed as not applicable to Vivotif. The case is considered non serious as per medical assessment.; Sender's Comments: It was reported that a consumer took only 3 out of 4 Vivotif capsules (incomplete course of vaccination). Considering the case information, the causality of incomplete course of vaccination is assessed as not applicable to Vivotif. The case is considered non serious as per medical assessment.
Muscle that injection was given near is extremely limited in mobility. Arm is not sore as it is at the needle site typically, it's a range of motion issue. I cannot move my arm certain ways since the booster shot.
This spontaneous report was received from a certified medical assistant and refers to a child of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported. On 02-SEP-2015, the patient was vaccinated with an improperly stored dose of M-M-R II (lot # L007578 with an expiration date on 05-MAR-2017; dose and route of administration were not provided). No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information is not expected because there was no consent for further contact.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable consumer. The reporter is the patient. A 39-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 01Apr2021 as dose 1, single (Lot number: ER8727), in left arm, on 26Apr2021 as dose 2, single (Lot number: ER8735), in left arm and on 10Jan2022 as dose 3 (booster), single (Lot number: FJ1611) at the age of 39 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "endometriosis" (unspecified if ongoing); "migraines" (unspecified if ongoing); "Allergies: Penicillin" (unspecified if ongoing). There were no concomitant medications. Patient had not received other medication in 2 weeks. Past drug history included: Morphine, reaction(s): "allergies"; Fentanyl, reaction(s): "allergies"; Tramedol, reaction(s): "allergies". Patient received Paxlovid (Lot number: Gc2897) from 06Jul2022 to 11Jul2022 for Covid-19 treatment. Outcome of the events was unknown.
This case was reported by a consumer via call center representative and described the occurrence of extremities hot feeling of in a adult female patient who received SHINGRIX for prophylaxis. The patient's past medical history included chickenpox. Concurrent medical conditions included radioisotope scan, penicillin allergy and topical adhesive allergy. Concomitant products included Flu unspecified (Flu vaccine). In October 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, several days after receiving SHINGRIX and an unknown time after receiving Flu vaccine, the patient experienced extremities hot feeling of and rash. On an unknown date, the outcome of the extremities hot feeling of and rash were recovered/resolved. It was unknown if the reporter considered the extremities hot feeling of and rash to be related to SHINGRIX. Additional details were provided as follows: The patient also received flu vaccine on left arm on the same day of when SHINGRIX was received. The patient received a dose of SHINGRIX in the right arm. The patient had a reaction from elbow to shoulder on her right arm several days later. The area was very hot after the injection and then a rash came several days after the shot. The patient visited her physician and by the time he saw her, the rash was almost gone. The patient reported that she had a mosquito bite near the rash but there was no inflammation just a little rash.
Child vaccinated at 12 months presented at age 8 years with significant herpes zoster (shingles).
she was only able to draw up 0.2 ml of a Menveo vaccine after reconstitution; Product Complaint; This non-serious case was reported by a other health professional via call center representative and described the occurrence of underdose in a male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA759A, expiry date 30-NOV-2023) for prophylaxis. This case was associated with a product complaint.   On an unknown date, the patient received Menveo .2 ml. On an unknown date, an unknown time after receiving Menveo, the patient experienced underdose (Verbatim: she was only able to draw up 0.2 ml of a Menveo vaccine after reconstitution) and pharmaceutical product complaint (Verbatim: Product Complaint). The outcome of the underdose and pharmaceutical product complaint were unknown.   Additional Information: GSK Receipt Date- 27-MAR-2023 The reporter was a Medical Assistant.  The reporter called to report low fill of Menveo. She did administer this to a patient. No credit or replacement had been ordered, as their vaccines were provided by the local Health Department. The vaccine administration facility was the same as primary reporter. The reporter was consented to follow up via email
No adverse event; INADVERTANTLY ADMINISTERED ONLY STERILE DILUENT TO A PATIENT WITHOUT MIXING IT WITH THE MMR-II; INADVERTANTLY ADMINISTERED ONLY STERILE DILUENT TO A PATIENT WITHOUT MIXING IT WITH THE MMR-II; This spontaneous report as received from a physician refers to a patient of unknown age and gender. The patient's Medical history, concurrent conditions and concomitant medication were not reported.  On 29-NOV-2021, the patient was inadvertently administered only sterile diluent  ( MERCK STERILE DILUENT) 0.7 ml (lot# reported as T004403, internal validation not received, expiration date 13-OCT-2022)  (route of administration was not reported) without mixing it with Measles, Mumps, and rubella (wistar RA 27-3) virus vaccine, Live (M-M-R II) (product preparation error)  ( lot number- verification mail sent, expiry date: 13-OCT-2022). There was no other AE information reported.
After getting the high dose I had complete exhaustion confusion, mouth glands  swollen, lymph nodes hurt shingles like feeling all over. loss of taste and smell.
States developed rash 10/20/03 early am. No fever, but had rash that was welt-like with reddness. Ear infection last week on antibiotics Amoxicillin.
Developed Shingles; This spontaneous case was reported by a dietician (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (Developed Shingles) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.    Co-suspect product included non-company product VALACYCLOVIR [VALACICLOVIR] for an unknown indication.    No medical history was provided by the reporter.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient started VALACYCLOVIR [VALACICLOVIR] (unknown route) at an unspecified dose. On 04-Feb-2021, the patient experienced HERPES ZOSTER (Developed Shingles). At the time of the report, HERPES ZOSTER (Developed Shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Patient's father reported that patient received the second dose of COVID-19 vaccine at a vaccine clinic on Monday 6/7 and noticed a silver-dollar sized area of redness and swelling at the injection site today, 6/9. Denies any other symptoms.
Information has been received from a pharmacist concerning a 62 year old female patient. There was no pertinent medical history reported. The patient has no drug reactions/allergies. On 20-JUL-2015, the patient was vaccinated with a dose of 0.65 ml ZOSTAVAX (subcutaneous, lot number was reported as 1012475 and expiration date was 10-JUL-2016). The pharmacist reported that the patient was seen by an unspecified physician and prescribed an unspecified steroid, after receiving ZOSTAVAX. The pharmacist stated that the reason the patient was prescribed an unspecified steroid was because she "thought" the patient "sustained" an unspecified foot injury but she was unsure if the foot injury occurred before or after receiving ZOSTAVAX (assuming foot injury occurred after receiving ZOSTAVAX. At the time of reporting, causality and outcome of the event were unknown. Additional information has been requested. Lot number: 1012475 is not valid for ZOSTAVAX.
PATIENT CALLED 4/29/2021 STATING THAT HIS DR DID A BLOOD WORK AFTER 5 WEEKS AND TOLD HIM THAT HE DOESNT HAVE ANY ANTIBODIES AGANIST THE COVID.
patient is stating that he is experiencing  hair loss after getting the vaccine, he noticed the hair loss more pronounce 12 days after the vaccination
This case was received from a health professional on 09 July 2007. A 14-year-old female patient experienced "possible chorea" after receiving an injection of Menactra (lot number not reported). The vaccine was administered on 26 June 2007, and 24 hours later, on 27 June 2007, the patient developed possible chorea. No additional information was provided.
Soreness in arm noted after vaccine administration yesterday 11-3-16 redness and itching noted this morning 11-4-16.
Patient accompanied relative in clinic for their COVID19 vaccine. There was a leftover dose in clinic and the patient was asked if he would like a COVID19 vaccine. The patient was advised at this time the vaccine being given was Pfizer. Patient stated his second dose was scheduled for 04/20/21; however, would like to receive now as possible. Advised patient he must be a minimum of 21 days from the first dose; patient verbalized he was at least 21 days from first dose. Patient was provided second dose Pfizer vaccine and again advised that this was the vaccine he was receiving. After the patient waited the required 15 minutes in the lobby, he realized he had received the Moderna vaccine first dose.
Suspected vaccination failure; got a flu shot, I got the flu / got the shot one time , 2 months later got the flu; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, 2 months after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced vaccination failure (serious criteria GSK medically significant) and influenza. On an unknown date, the outcome of the vaccination failure and influenza were unknown.   It was unknown if the reporter considered the vaccination failure and influenza to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. It was reported that only time the patient got a flu shot, 2 months later the patient experienced the flu. The physician stated that it was a coincidence. The patient would take chances. This case was considered as suspected vaccination failure since the details regarding laboratory test was not provided.
1045  AFTER OBSER 15 MIN PT STATED HER FACE FELT HOT AND FLUSHED AND HAVING HT PALP. pULSE REGULAR AND NORMA   RATE. FACE FLUSHED BUT NOT DIAPHORETIC. DENIED NAUSEA, FAINT FEELING. DECLINED STRETCHER. OBSERVED.   10:45  PLACED O STRETCHER  130/98  HR 92  O2 99%FEELS BETTER,   11:15  sITTING ON SIDE STRETCHER FEELS BACK TO NORMAL PPT . 132/88  HR 87  O2 100%.  WARM AND DRY. DISCH HOME
Sore arm all day. Body aches all day but worst from 12-6pm and eased a lot by 9pm. Chills early in the morning 8am-12pm. Small bit of fatigue all day.
He was not sleeping couple of days; Have some like Sucker punch on his arm at the injection site; This is a spontaneous report from a contactable consumer (parent) from a Pfizer-sponsored program regulatory authority Support. This consumer reported information for two different patients. This is the second of two reports. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number, expiration date was not reported) at dose 1 single and dose 2 single (lot number, expiry date unknown); both via an unspecified route of administration, on an unspecified date for covid-19 immunization. Family medical history included allergy. The patient's concomitant medications were not reported. The patient was not sleeping from a couple of days and had something like sucker punch on his arm at the injection site on an unspecified date. It was reported the second dose is worser than the first dose. The outcome of the event was unknown.    The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101116868 same reporter/drug and different patient.
Patient stated that he received the second dose of Moderna vaccine on Friday March 19th. Today, March 23 at approximately 2 AM, the patient stated that he woke up to "his legs jerking". He stated that the jerking/spasms started in his feet and rose up to his knees. The patient stated that he got up to walk after a few minutes and the spasms slowly stopped. He states that his legs feel "odd" now, but cannot put to words the feelings. States that it feels like what he would imagine restless leg syndrome to feel like.
Large area of redness and warmth at vaccine sites on left thigh. No induration, no signs of infection. Two injections were given in left thigh.
A serious spontaneous report of exposure during pregnancy and pure red blood cell aplasia has been received from a consumer concerning a 34-year-old female, subsequent to FLUMIST. Medical history included the patient was six weeks pregnant. No obstetrical history or other relevant medical history were provided. Concomitant medications were not reported. The patient received FLUMIST on 28-Oct-2011. On 09-Nov-2011, the patient experienced lethargy, tiredness and feeling her pulse beat in her head. She underwent a bone marrow biopsy and was diagnosed with pure red blood cell aplasia. Per the reporter, the patient's physicians stated that the patient's immune system went into hyper drive and her red blood cells went low with severe anemia. At the time of this report the patient was doing fine and everything was back to normal. The outcome of the events of pregnancy and pure red blood cell aplasia was resolved.
Soreness; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Soreness). At the time of the report, PAIN (Soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Relevant concomitant medications was reported. Treatment information was not provided.
My COVID-19 symptoms started on 12/29/2022 in the morning at 8:00AM. I experienced loss of appetite, and fatigue. I did a COVID-19 home rapid test which was negative. On 12/30/2022 I did another rapid test which was negative again. I scheduled a PCR test on 12/30/2022 at a COVID clinic which was positive. I spoke to a doctor from a hospital who prescribed me with PAXLOVID for 5 days.
Pt received vaccine at health clinic on 1/10/19, pt started to feel pain and unable to move his left arm. Finally pt thought something is wrong and came to our office on 1/22/2019. Dr ordered VOLTAREN gel, ADVIL, TYLENOL and Physical Therapy. No outcome as this just was started yesterday.
CHEST PALPITATIONS WHEN SWALLOWING/SHARP CHEST PAINS.  SMALL BLIND SPOTS/FLOATING BLIND SPOTS IN VISION
Information has been received from a registered nurse concerning a 36 year old female hospital employee with a history of back injury who in 2000 was vaccinated with two doses of varicella vaccine. Concomitant therapy included unspecified anti-inflammatory drugs and unspecified pain medication. The registered nurse reported that the pt's titer pre-vaccination was 0.6 and her titer post-vaccination was 0.7. Unspecified medical attention was sought. Additional info has been requested.
FIRTS: TIREDNESS, ARM PAIN,  ONE WEEK LATER: FEVER, MUSCLE ACHE, HEADACHE, EAR ACHE, THIRST
Bell's palsy; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program.  A patient of unknown gender and age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unknown date at single dose for COVID-19 immunisation. Medical history and concomitant medications were unknown. The patient got Bell's palsy after the 1st dose on unknown date. The outcome of the vent was unknown. Information on the lot/batch number has been requested.
Developed CRPS, aka reflexive sympathetic dystrophy.  Chronic, life-long condition causing severe muscle, joint and nerve pain, loss of use of right hand.
Nausea 72hrs Diarrhea 72hrs Chills 72hrs Cold sweats 72hrs Unable to keep any liquids or foods down 72hrs Sore arm 48hrs No energy. 72hrs Ringing sound in head with headache (like TV ringing sound) 72hrs
Vesicles on trunk. Fever (but with (B) Otitis media). T=105.0
After she was vaccinated she said " I need to lay down "  I need water" "I get anxious " she stared look pale. she ask to let her lay down on the floor we assisted her to the floor and called rapid response. I put some alcohol  behind her ears and brought a wheel chair.  she was able to get on the chair we took  vitals @2:52 BP 113/76, P 73, O2 95 she said "This happens all the time when I get shots" . Response team arrived and saw that vitals were good and offered her to go to the ER to get checked out and she refused. I took her vitals again  @3:05 125/65, P 70, O2 97. Took her to the hallway she wait 30min and she looks  and said she was ok and insisted " this happen all the time i get a vaccine." I then  walked her to the parking lot.
ALLERGIC REACTION, INIT 2/22/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
HTN in AM 191/106. Swelling, hard and pain and hot at injection site. No redness. Pressure in head, went to ER.